The Interplay between Alpha-Synuclein Clearance and Spreading

被引:84
|
作者
da Fonseca, Tomas Lopes [1 ,2 ]
Villar-Pique, Anna [1 ]
Outeiro, Tiago Fleming [1 ,2 ,3 ]
机构
[1] Univ Med Ctr Gottingen, Dept Neurodegenerat & Restorat Res, Ctr Nanoscale Microscopy & Mol Physiol Brain, D-37073 Gottingen, Germany
[2] Univ Lisbon, Inst Fisiol, Fac Med, P-1649028 Lisbon, Portugal
[3] Univ Nova Lisboa, CEDOC, Fac Ciencias Med, P-1150 Lisbon, Portugal
来源
BIOMOLECULES | 2015年 / 5卷 / 02期
关键词
D O I
10.3390/biom5020435
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Parkinson's Disease (PD) is a complex neurodegenerative disorder classically characterized by movement impairment. Pathologically, the most striking features of PD are the loss of dopaminergic neurons and the presence of intraneuronal protein inclusions primarily composed of alpha-synuclein (alpha-syn) that are known as Lewy bodies and Lewy neurites in surviving neurons. Though the mechanisms underlying the progression of PD pathology are unclear, accumulating evidence suggests a prion-like spreading of alpha-syn pathology. The intracellular homeostasis of alpha-syn requires the proper degradation of the protein by three mechanisms: chaperone-mediated autophagy, macroautophagy and ubiquitin-proteasome. Impairment of these pathways might drive the system towards an alternative clearance mechanism that could involve its release from the cell. This increased release to the extracellular space could be the basis for alpha-syn propagation to different brain areas and, ultimately, for the spreading of pathology and disease progression. Here, we review the interplay between alpha-syn degradation pathways and its intercellular spreading. The understanding of this interplay is indispensable for obtaining a better knowledge of the molecular basis of PD and, consequently, for the design of novel avenues for therapeutic intervention.
引用
收藏
页码:435 / 471
页数:37
相关论文
共 50 条
  • [1] Spreading of alpha-synuclein between different cell types
    Ruf, Wolfgang P.
    Meirelles, Joao L.
    Danzer, Karin M.
    BEHAVIOURAL BRAIN RESEARCH, 2023, 436
  • [2] Spreading of alpha-synuclein - relevant or epiphenomenon?
    Killinger, Bryan A.
    Kordower, Jeffrey H.
    JOURNAL OF NEUROCHEMISTRY, 2019, 150 (05) : 605 - 611
  • [3] Unraveling the Complex Interplay between Alpha-Synuclein and Epigenetic Modification
    Sugeno, Naoto
    Hasegawa, Takafumi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (07)
  • [4] The interplay between Purinergic signaling and the toxicity of extracellular alpha-synuclein
    Wilkaniec, A.
    Cieslik, M.
    Gazssowska, M.
    Jesko, H.
    Czapski, G.
    Lenkiewicz, A.
    Adamczyk, A.
    JOURNAL OF NEUROCHEMISTRY, 2015, 134 : 136 - 136
  • [5] Alpha-synuclein spreading in Parkinson's disease
    Recasens, Ariadna
    Dehay, Benjamin
    FRONTIERS IN NEUROANATOMY, 2014, 8
  • [6] Brain regions susceptible to alpha-synuclein spreading
    Guo, Yu-Jie
    Xiong, Huan
    Chen, Kang
    Zou, Jin-Jun
    Lei, Peng
    MOLECULAR PSYCHIATRY, 2022, 27 (01) : 758 - 770
  • [7] Brain regions susceptible to alpha-synuclein spreading
    Yu-Jie Guo
    Huan Xiong
    Kang Chen
    Jin-Jun Zou
    Peng Lei
    Molecular Psychiatry, 2022, 27 : 758 - 770
  • [8] Alpha-Synuclein as a Mediator in the Interplay between Aging and Parkinson's Disease
    Bobela, Wojciech
    Aebischer, Patrick
    Schneider, Bernard Laurent
    BIOMOLECULES, 2015, 5 (04): : 2675 - 2700
  • [9] Cortical Spreading Depression in Alpha-Synuclein Knockout Mice
    Pelkonen, Anssi
    Yavich, Leonid
    SYNAPSE, 2012, 66 (01) : 81 - 84
  • [10] Viral alpha-synuclein knockdown prevents spreading synucleinopathy
    Menon, Sindhu
    Kofoed, Rikke H.
    Nabbouh, Fadl
    Xhima, Kristiana
    Al-Fahoum, Yasmeen
    Langman, Tammy
    Mount, Howard T. J.
    Shihabuddin, Lamya S.
    Sardi, S. Pablo
    Fraser, Paul E.
    Watts, Joel C.
    Aubert, Isabelle
    Tandon, Anurag
    BRAIN COMMUNICATIONS, 2021, 3 (04)